- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 211/38 - Halogen atoms or nitro radicals
Patent holdings for IPC class C07D 211/38
Total number of patents in this class: 193
10-year publication summary
11
|
15
|
16
|
15
|
8
|
18
|
11
|
12
|
15
|
8
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Alkermes Pharma Ireland Limited | 272 |
9 |
Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 820 |
8 |
3m Innovative Properties Company | 17842 |
7 |
Janssen Pharmaceutica N.V. | 3432 |
4 |
Theravance Biopharma R&D IP, LLC | 462 |
4 |
Vividion Therapeutics, Inc. | 33 |
4 |
F. Hoffmann-La Roche AG | 7920 |
3 |
Boehringer Ingelheim International GmbH | 4701 |
3 |
Massachusetts Institute of Technology | 10002 |
3 |
California Institute of Technology | 3966 |
3 |
Toray Industries, Inc. | 6886 |
3 |
National Institute of Advanced Industrial Science and Technology | 3784 |
3 |
The Broad Institute, Inc. | 1776 |
3 |
ChemoCentryx, Inc. | 389 |
3 |
Jiangsu Kanion Pharmaceutical Co., Ltd. | 81 |
3 |
OPKO Health, Inc. | 49 |
3 |
Taisho Pharmaceutical Co., Ltd. | 859 |
3 |
Teijin Pharma Limited | 257 |
3 |
Teika Pharmaceutical Co., Ltd. | 35 |
3 |
Toyama Chemical Co., Ltd. | 103 |
3 |
Other owners | 115 |